RK
Rajesh Kumar
Massachusetts General Hospital/Harvard Medical School, Hospices CHUV, Universite de Lausanne
0000-0002-0211-7195
About
I obtained my PhD in Cellular-Molecular Biology/Immunology from University of Lausanne, Switzerland.
Employment
-
Massachusetts General Hospital/Harvard Medical School Research Fellow2016 - Present
-
Hospices CHUV Postdoc2013 - 2016
Education
-
Universite de Lausanne PhD2009 - 2013
Projects & Funding
Projects & funding information is unavailable.
Publications (12)
- Differential Effects of the Mitochondria-Active Tetrapeptide SS-31 (D-Arg-dimethylTyr-Lys-Phe-NH2) and Its Peptidase-Targeted Prodrugs in Experimental Acute Kidney Injury. Save
- Editorial: Mechanisms Safeguarding the Trophoblast Multipotent State Save
- How can molecular abnormalities influence our clinical approach. Save
- Targeted gamma-secretase inhibition of Notch signaling activation in acute renal injury. Save
- IL-2-mediated in vivo expansion of regulatory T cells combined with CD154-CD40 co-stimulation blockade but not CTLA-4 Ig prolongs allograft survival in naive and sensitized mice Save
- Update on Dendritic Cell-Induced Immunological and Clinical Tolerance. Save
- Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases Save
- Additive effects of rapamycin and aspirin on dendritic cell allostimulatory capacity Save
- Targeted γ-Secretase Inhibition To Control the Notch Pathway in Renal Diseases Save
- Lipoxin A<inf>4</inf> prevents the progression of de novo and established endometriosis in a mouse model by attenuating prostaglandin E<inf>2</inf> production and estrogen signaling Save